Wednesday, Aug 7: 10:30 AM - 12:20 PM
1019
Invited Panel Session
Oregon Convention Center
Room: CC-F150
Topic: Role of a Statistician in Drug Development in AI World
Abstract: AI and statisticians both handle significant amount of data. Can AI tools and statisticians offer the most desirable human-machine collaboration to advance solutions of complex problems that we have? Is there an ideal role of AI tools in conceptual design and optimization of clinical trials including identification of biomarkers? Are there risks of non-statisticians using AI tools and assume roles of pseudo statisticians to make wrong decisions? What are the most exciting advantages of AI as a tool to statisticians? Will there be best practices and guidance to use an AI tool in near future?
Panelists:
Brian Tracey
Director, Statistics,
Takeda, Boston, MA
brian.tracey@takeda.com
Paul Schuette
Scientific Computing Coordinator for the Office of Biostatistics – CDER, FDA
Silver Springs, Maryland
Paul.Schuette@fda.hhs.gov
Chris Miller
Vice President - Biometrics
Astra Zeneca
Gaithersburg - Maryland
chris.miller@astrazeneca.com
Kent Koprowicz
Vice President, DMC - Cytel
kent.koprowicz@cytel.com
Xiaochun Li, Professor
Department of Biostatistics and Health Data Science
Center for Computational Biology and Bioinformatics
School of Medicine, Fairbanks School of Public Health,
Indiana University, Indianapolis, IN
xiaochun@iu.edu
Applied
Yes
Main Sponsor
Section for Statistical Programmers and Analysts
Co Sponsors
Biopharmaceutical Section
Section on Statistical Computing